Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Among participants who met criteria for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) at baseline, more than 80% in the 8mg and 12mg cohorts no longer met those criteria after treatment effectively resolving their fatty liver disease
In each treatment session, approximately 24% of the adipocytes within a targeted area undergo apoptosis, leading to a reduction in local fat stores
Medical experts emphasize that most side effects typically appear during dose adjustments and often improve over time
A faster onset of any GLP-1 side effects like nausea
Schedule: Daily subcutaneous injections for 8 weeks (standard cycle)
US$ 23.20
US$ 25.93
US$ 23.83
)
US$ 21.91
US$ 26.23
US$ 25.29
US$ 24.14
